Major biosecurity gaps exist globally: no alert system for new viruses and no way to monitor private lab research.

There is no legal mechanism to inspect private labs for pathogen research unless they are registered under the Federal Select Agent Program, creating a regulatory blind spot.

“Our blind spot is the work that's happening in private labs. We don't actually have any legal mechanism for going into a private lab and determining are they doing certain kinds of pathogen research other than whether they have registered under the Federal Select Agent Program.”